Appendix: 두 판 사이의 차이

urowiki
둘러보기로 이동 검색으로 이동
잔글 (→‎약어)
1번째 줄: 1번째 줄:
=약어집=
=약어집=
{| class="wikitable"
!Abbreviation 
!a key to Abbreviations
|-
|ABR
|Absolute bed rest
|-
|AGP
|Antegrade pyelography
|-
|A-line
|Arterial line
|-
|Anti.
|Antibiotics
|-
|ARF
|Acute renal failure
|-
|BM
|Bone marrow
|-
|BR
|Bed rest
|-
|BST
|Blood sugar test
|-
|BT
|Bleeding time
|-
|BWt
|Body weight 
|-
|Bx
|Biopsy
|-
|C-line
|Central line
|-
|CRF
|Chronic renal failure
|-
|CrCl 
|Creatinine clearance
|-
|CVP
|Central venous pressure
|-
|DIC
|Disseminated intravascular coagulation
|-
|D-J
|Double-J catheter
|-
|E'
|Electrolyte
|-
|FBS
|Fasting blood glucose
|-
|FFP
|Fresh frozen plasma
|-
|F/U
|Follow up
|-
|G.O
|Gas out
|-
|Hb 
|Hemoglobin 
|-
|Hct
|Hematocrit
|-
|HD
|Hemodialysis
|-
|H/S
|Hartman solution
|-
|HTN
|Hypertension 
|-
|I/O
|Input/Output
|-
|IV
|Intravenous
|-
|LD
|Liquid diet
|-
|LFT
|Liver function test
|-
|L-tube
|Levin tube
|-
|NRD
|Normal regular diet
|-
|N/S
|Normal saline
|-
|OP
|Operation
|-
|OSM
|Osmolarity
|-
|P/C
|Platelet concentrate
|-
|PCA
|Patient-controlled analgesia
|-
|PCN
|Percutaneous nephrostomy
|-
|PFT
|Pulmonary function test
|-
|PO
|By mouth, orally 
|-
|POD
|Post-operative day
|-
|PSA 
|Prostate specific antigen
|-
|PT
|Prothrombin time
|-
|qd
|Once daily
|-
|RGP
|Retrograde pyelography
|-
|SD
|Soft diet
|-
|SOW
|Seeps of water
|-
|TD
|Tolerable diet
|-
|TPN
|Total parenteral nutrition
|-
|TURB 
|Transurethral resection of bladder
|-
|TURP
|Transurethral resection of prostate
|-
|U.O
|Urine output
|-
|USG
|Ultrasonography
|-
|V/S
|Vital sign
|-
|W/B
|Whole blood
|-
|W/U
|Work up 
|}


=비뇨기계 종양의 병기=
=비뇨기계 종양의 병기=
== Kidney cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)
{| class="wikitable"
!T category
! colspan="3" |T criteria
|-
|TX
| colspan="3" |Primary tumor cannot be assessed
|-
|T0
| colspan="3" |No evidence of primary tumor
|-
|T1
| colspan="3" |Tumor ≤7 cm in greatest dimension, limited to the kidney
|-
|T1a
| colspan="3" |Tumor ≤4 cm in greatest dimension, limited to the kidney
|-
|T1b
| colspan="3" |Tumor >4 cm but ≤7 cm in greatest dimension, limited to the kidney
|-
|T2
| colspan="3" |Tumor >7 cm in greatest dimension, limited to the kidney
|-
|T2a
| colspan="3" |Tumor >7 cm but ≤10 cm in greatest dimension, limited to the kidney
|-
|T2b
| colspan="3" |Tumor >10 cm, limited to the kidney
|-
|T3
| colspan="3" |Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota's fascia
|-
|T3a
| colspan="3" |Tumor extends into the renal vein or its segmental branches, or invades the pelvicalyceal system, or invades perirenal and/or renal sinus fat but not beyond Gerota's fascia
|-
|T3b
| colspan="3" |Tumor extends into the vena cava below the diaphragm 
|-
|T3c
| colspan="3" |Tumor extends into the vena cava above the diaphragm or invades the wall of the vena cava
|-
|T4
| colspan="3" |Tumor invades beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland)
|-
| colspan="4" |Regional lymph nodes (N)
|-
|N category
| colspan="3" |N criteria
|-
|NX
| colspan="3" |Regional lymph nodes cannot be assessed
|-
|N0
| colspan="3" |No regional lymph node metastasis
|-
|N1
| colspan="3" |Metastasis in regional lymph node(s)
|-
| colspan="4" |Distant metastasis (M)
|-
|M category
| colspan="3" |M criteria
|-
|M0
| colspan="3" |No distant metastasis
|-
|M1
| colspan="3" |Distant metastasis
|-
| colspan="4" |Prognostic stage groups
|-
|When T is... 
|And N is...
|And M is... 
|Then the stage group is... 
|-
|T1
|N0
|M0
|I
|-
|T1
|N1
|M0
|III
|-
|T2
|N0
|M0
|II
|-
|T2
|N1
|M0
|III
|-
|T3
|NX, N0
|M0
|III
|-
|T3
|N1
|M0
|III
|-
|T4
|Any N
|M0
|IV
|-
|Any T
|Any N
|M1
|IV
|}
TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.
== Tumors of the renal pelvis and ureter TNM staging AJCC UICC 2017 ==
Primary tumor (T)
TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.
== Bladder cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)
TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.
== Prostate cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)
TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.
== Testicular cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)
TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control; LDH: lactate dehydrogenase; hCG: human chorionic gonadotropin; AFP: alphafetoprotein.
== Urethral cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)
TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.
== Cancer of the penis TNM staging AJCC UICC 2017 ==
Primary tumor (T)
TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control; ENE: extranodal extension.


=실험실검사 참조수치=
=실험실검사 참조수치=
== TABLE 1. Hematology and Coagulation ==
== TABLE 2. Clinical Chemistry and Immunology ==
== TABLE 3. Classification of LDL, Total, and HDL Cholesterol ==
== TABLE 4. Urine Analysis and Renal Function Tests ==
== TABLE 5. Body Fluids and Other Mass Data ==


=비뇨기과 상병코드=
=비뇨기과 상병코드=

2019년 5월 23일 (목) 07:38 판

약어집

Abbreviation  a key to Abbreviations
ABR Absolute bed rest
AGP Antegrade pyelography
A-line Arterial line
Anti. Antibiotics
ARF Acute renal failure
BM Bone marrow
BR Bed rest
BST Blood sugar test
BT Bleeding time
BWt Body weight 
Bx Biopsy
C-line Central line
CRF Chronic renal failure
CrCl  Creatinine clearance
CVP Central venous pressure
DIC Disseminated intravascular coagulation
D-J Double-J catheter
E' Electrolyte
FBS Fasting blood glucose
FFP Fresh frozen plasma
F/U Follow up
G.O Gas out
Hb  Hemoglobin 
Hct Hematocrit
HD Hemodialysis
H/S Hartman solution
HTN Hypertension 
I/O Input/Output
IV Intravenous
LD Liquid diet
LFT Liver function test
L-tube Levin tube
NRD Normal regular diet
N/S Normal saline
OP Operation
OSM Osmolarity
P/C Platelet concentrate
PCA Patient-controlled analgesia
PCN Percutaneous nephrostomy
PFT Pulmonary function test
PO By mouth, orally 
POD Post-operative day
PSA  Prostate specific antigen
PT Prothrombin time
qd Once daily
RGP Retrograde pyelography
SD Soft diet
SOW Seeps of water
TD Tolerable diet
TPN Total parenteral nutrition
TURB  Transurethral resection of bladder
TURP Transurethral resection of prostate
U.O Urine output
USG Ultrasonography
V/S Vital sign
W/B Whole blood
W/U Work up 

비뇨기계 종양의 병기

Kidney cancer TNM staging AJCC UICC 2017

Primary tumor (T)

T category T criteria
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
T1 Tumor ≤7 cm in greatest dimension, limited to the kidney
T1a Tumor ≤4 cm in greatest dimension, limited to the kidney
T1b Tumor >4 cm but ≤7 cm in greatest dimension, limited to the kidney
T2 Tumor >7 cm in greatest dimension, limited to the kidney
T2a Tumor >7 cm but ≤10 cm in greatest dimension, limited to the kidney
T2b Tumor >10 cm, limited to the kidney
T3 Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota's fascia
T3a Tumor extends into the renal vein or its segmental branches, or invades the pelvicalyceal system, or invades perirenal and/or renal sinus fat but not beyond Gerota's fascia
T3b Tumor extends into the vena cava below the diaphragm 
T3c Tumor extends into the vena cava above the diaphragm or invades the wall of the vena cava
T4 Tumor invades beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland)
Regional lymph nodes (N)
N category N criteria
NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in regional lymph node(s)
Distant metastasis (M)
M category M criteria
M0 No distant metastasis
M1 Distant metastasis
Prognostic stage groups
When T is...  And N is... And M is...  Then the stage group is... 
T1 N0 M0 I
T1 N1 M0 III
T2 N0 M0 II
T2 N1 M0 III
T3 NX, N0 M0 III
T3 N1 M0 III
T4 Any N M0 IV
Any T Any N M1 IV

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Tumors of the renal pelvis and ureter TNM staging AJCC UICC 2017

Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Bladder cancer TNM staging AJCC UICC 2017

Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Prostate cancer TNM staging AJCC UICC 2017

Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Testicular cancer TNM staging AJCC UICC 2017

Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control; LDH: lactate dehydrogenase; hCG: human chorionic gonadotropin; AFP: alphafetoprotein.

Urethral cancer TNM staging AJCC UICC 2017

Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.

Cancer of the penis TNM staging AJCC UICC 2017

Primary tumor (T)

TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control; ENE: extranodal extension.

실험실검사 참조수치

TABLE 1. Hematology and Coagulation

TABLE 2. Clinical Chemistry and Immunology

TABLE 3. Classification of LDL, Total, and HDL Cholesterol

TABLE 4. Urine Analysis and Renal Function Tests

TABLE 5. Body Fluids and Other Mass Data

비뇨기과 상병코드

원본 주소 "http://urowiki.or.kr/wiki2/index.php?title=Appendix&oldid=2320"